A ‘smart-connected cup’ to fight Zika
By combining a a Thermos, a microfluidics chip and a smartphone, researchers have found a way to bring Zika testing to sites where clinical laboratories aren’t present but diagnostics are needed.
A cryptocurrency collaboration
A partnership with Ripple, the University Blockchain Research Initiative, will bring innovation to cryptocurrency and blockchain.
A chemotherapy companion to save thousands of lives
A trio of Penn students created the startup Sanguis, producing an inexpensive, portable blood cell counting device.
A legacy of innovation at Pennovation Works
Visitors participating in a Jane’s Walk will tour Penn’s technology and innovation hub, and learn about the history of the area’s deep inventive roots.
FDA approves CAR T therapy for large B-Cell lymphoma developed at Penn
The nation’s first approved personalized cellular therapy is now available for a second indication.
Student startups on view
On Friday, April 27, University students with innovative startups will join with investors for the Penn Wharton Startup Showcase.
Carl June named one of TIME Magazine’s Most Influential People
His work on CAR-T cancer treatment was approved by the FDA in 2017, and this year June is celebrated as an influential global pioneer.
The Sachs Program for Arts Innovation announces 23 project grants
At a special event featuring a performance by John Waters and remarks by President Amy Gutmann, the late Keith Sachs was celebrated and $123,000 of grants were doled out for arts projects.
How working dogs are sniffing out cancer
A Center for Public Health Initiatives seminar showcased the collaborative research at Penn and the Monell Chemical Senses Center that is working to detect early stage ovarian cancer.
Three years on: A look at the Penn Wharton China Center
The impact of the Beijing-based center and research fund has been far-reaching on campus and in China.
In the News
Penn Invests $50 million in Biotech in a Bold Bid to Build Philly’s Innovation Cluster
Kevin B. Mahoney of the Perelman School of Medicine and UPHS confirmed Penn’s plans to invest in biotech companies, with long-range goals “to create jobs, synergy and an innovation cluster around Penn technology and spin outs.”
FULL STORY →
Penn Makes Third Big Biotech Bet, Helping to Raise $53M for Carisma
Cancer-fighting biotech company Carisma Therapeutics Inc. is the latest addition to Penn’s recently-announced investment plan. Roy Rosin, CIO at Penn Medicine, said, “Penn’s commitment is pretty exciting for this region.”
FULL STORY →